Iclusig45 (Ponatinib Tablet) 45mg

Iclusig 45mg tablets contain ponatinib, a kinase inhibitor prescribed for certain blood cancers. This oral treatment is used when other therapies are unsuitable. Store at room temperature and follow medical guidance for safe use.

Strength

45mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Incyte Biosciences

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ponatinib 45mg tablets are used to treat chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. It is prescribed when other tyrosine kinase inhibitors have not worked or when specific genetic mutations are present. This medication helps control abnormal cell growth by targeting specific proteins in cancer cells.

Side Effects

Ponatinib 45mg may cause side effects such as fatigue, rash, or digestive discomfort. Some patients experience headaches or joint pain. These effects vary and may lessen over time. Regular monitoring by a healthcare provider is recommended to manage any reactions.

Precautions & Warnings

Keep ponatinib 45mg tablets in a cool, dry place away from moisture and direct sunlight. Store at room temperature and ensure the bottle is tightly closed when not in use. Always follow the handling instructions provided with the medication to maintain its effectiveness.

Avoid Interactions

Ponatinib can interact with other medications, including certain blood thinners, antifungals, and herbal supplements. Avoid grapefruit products as they may affect how the drug works. Discuss all current medications with a healthcare provider before starting ponatinib to minimize risks.

Frequently Asked Questions

Ponatinib 45mg is used to treat chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.

Store ponatinib 45mg tablets at room temperature in a dry place, away from moisture and direct sunlight.

Ponatinib may interact with other drugs; consult a healthcare provider before combining medications.

Common side effects may include fatigue, rash, headaches, or digestive discomfort.

Ponatinib is a targeted therapy, not a traditional chemotherapy, as it works by blocking specific proteins in cancer cells.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.